Results from this study demonstrated clearly that Metformin reversed MMe-like phenotype in circulation of T2DM as it significantly suppressed CD68, IL-6, iNOS, TNFα, and CD36 expression and increased CD11c, CD163 and CD169 expression in T2DM. This evidence concerns the gene IL6 and type 2 diabetes mellitus.